Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy.
Bora
Emre
E
Saffet Gonul
Ali
A
Akdeniz
Fisun
F
Vahip
Simavi
S
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004565:Electroconvulsive Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D009460:Neurologic Examination / Q000187:drug effects; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D000069348:Quetiapine Fumarate; D012307:Risk Factors
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate